---
title: Biologic Disease-Modifying Antirheumatic Drugs (aka â€œBiologicsâ€ or Biologic DMARDs)
date: "2023-01-22"
enableToc: false
---

> [!info]
>
> ğŸŒ± ä¾†è‡ª: [[Huppert's Notes]]

# Biologic Disease-Modifying Antirheumatic Drugs (aka â€œBiologicsâ€ or Biologic DMARDs) #ğŸš§ æ–½å·¥ä¸­

### Biologic Disease-Modifying Antirheumatic Drugs (aka â€œBiologicsâ€ or Biologic DMARDs)

â€¢Â Â Â Definition: DMARDs that work by targeting immune system pathways

â€¢Â Â Â General principles of use:

-Â Â Â Screen for chronic infections prior to starting biologic DMARD therapy: Tuberculosis (PPD or IGRA), HepB, HepC, HIV

-Â Â Â Biologic DMARD administration: Subcutaneous medications can be self-administered; IV medications are administered at an infusion center

-Â Â Â Lab monitoring: Check CBC/CMP q2â€“3 months to evaluate for cytopenias and check renal/hepatic function

-Â Â Â Do not administer live vaccines while on biologics, including live influenza vaccine, Zostavax (â†’ use Shingrix instead), yellow fever vaccine

-Â Â Â Nomenclature: See Table 9.15 for structure-suffix relationships for therapeutic antibodies


**TABLE 9.15** â€¢ Structure-Suffix Relationship of Therapeutic Antibodies





**TABLE 9.16** â€¢ Non-Biologic DMARDs





**TABLE 9.17** â€¢ Biologic DMARDs




â€¢Â Â Â Medications: See Table 9.17

